Paul Thomas, Ph.D., an assistant member of the Department of Immunology at St. Jude Children's Research Hospital, is corresponding author on a study that identifies factors that predict flu severity in patients and sets the stage for more effective therapies to prevent flu complications and deaths. Credit: Ann-Margaret Hedges, St. Jude Children's Research Hospital
St. Jude Children's Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue of the American Journal of Respiratory and Critical Care Medicine.
The discovery came after investigators tracked flu infections for 28 days in 84 individuals with community-acquired influenza. The study is still underway. This report focused on the 2009-2010 and 2010-2011 flu seasons.
Researchers found that patients with elevated levels of three particular immune system regulators, or cytokines, early in the infection were more likely to develop severe flu symptoms and to be hospitalized than patients with lower levels of the same regulators. Study participants ranged in age from 3 weeks to 71 years old and included 41 infants and toddlers aged 23 months or younger.
The cytokine levels early in the infection were predictive of flu-related complications regardless of patient age, flu strain, the ability of the virus to replicate and other factors. The cytokines involved help to regulate inflammation driven by the innate immune response. The innate immune system serves as the frontline of the body's defense against flu and other threats until antibodies and T cells are ready to provide a more targeted defense.
Study participants were recruited by research collaborators at Le Bonheur Children's Medical Center, a general children's hospital in Memphis, where patients are still being enrolled in the study. Researchers also plan to check for immune signatures in flu patients from sites in the U.S., Egypt, Colombia and other nations.
"Patients in this study could handle the flu virus and clear it from their lungs in a week to 10 days. The problem for patients with this immune signature is likely the inflammatory environment in their airways created by the innate immune system in response to the virus," said corresponding author Paul Thomas, Ph.D., an assistant member of the St. Jude Department of Immunology. "Clinically, we need to explore targeted therapies to address this problem separately from efforts to clear the virus."
The findings provide insight into why the benefits of the antiviral drug oseltamivir diminish early in the infection. "This drug helps get rid of the virus, but these patients do not appear to have a problem with that," Thomas explained.
Flu remains a leading cause of illness and death worldwide. In this study, 19 patients were hospitalized, including four who were admitted to an intensive care unit.
For this study, researchers tracked both the flu infection and the resulting immune response through blood, nasal swabs and nasal wash samples collected from patients with laboratory-confirmed flu. Sampling began when patients sought medical attention for flu symptoms and was repeated on days 3, 7, 10 and 28. Along with measuring levels of flu virus in the nose and sinuses, researchers measured 42 cytokines and antibodies against circulating flu viruses.
This is one of the first studies to examine the immune response in both the blood and in the nose and sinuses, where the infection begins. The patients included 24 who qualified as high risk for flu complications due to asthma and certain other underlying medical conditions. Similar sampling was conducted on 126 volunteers recruited from the households of flu patients.
The testing showed children and adults were equally successful at eliminating the virus regardless of the subtype. In fact, based on cytokine levels in the blood, nose and sinuses of patients, children mounted a more aggressive inflammatory response than adults. "The fact that the innate immune response was stronger in the airways of children than adults was a surprise. Previous studies using different measures reported that children mounted a weaker immune response," said first author Christine Oshansky, Ph.D., a St. Jude postdoctoral fellow. In this study, the hyperactive immune response diminished with age, but Thomas said it may help explain why toddlers and infants are more likely to develop severe flu symptoms. Normal genetic variation might play a role in the innate immune response, he added.
When researchers dissected the inflammatory response, they found that elevated nasal levels of the cytokines MCP-3 and interferon alpha 2 (IFNa2) and elevated blood levels of interleukin 10 (IL-10) at diagnosis predicted more severe symptoms later. Increased blood levels of IL-10 and MCP-3, as well as interleukin-6, at diagnosis predicted hospitalization later. MCP-3 and IFNa2 promote inflammation. IL-10 suppresses inflammation. Elevated IL-10 levels often signal that the body is trying to shut down the inflammatory response.
Researchers also found evidence linking inflammatory cytokine levels to white blood cells called monocytes that are recruited to the site of the infection. Through cytokine secretion and other activities, different types of monocytes have the ability to orchestrate a variety of inflammatory responses. Some responses are likely beneficial, but some may hinder patient recovery. Work has begun to better understand what regulates production and movement of different monocyte populations as a way to better explain differences in the inflammatory response to flu.
Explore further: Researchers identify risks for death from H7N9 avian flu virus
Medical Xpress on facebook
Related Stories
Researchers identify risks for death from H7N9 avian flu virus
Dec 24, 2013
(Medical Xpress)—Since March 2013, the avian flu virus H7N9 has infected 134 people and caused 44 deaths. Among those infected, many, but not all, patients develop severe symptoms, including pneumonia and ...
Study finds some people less susceptible to H7N9 influenza virus than others
Jan 07, 2014
(Medical Xpress)—An international team of researchers working at the University of Melbourne in Australia has found that genetic differences in people result in different degrees of ability to fight the ...
The rocky road to a better flu vaccine
Jan 23, 2014
Currently approved flu vaccines are less effective in the elderly, yet an estimated 90% of influenza-related deaths occur in people over 65. A paper published on January 23rd in PLOS Pathogens reports on the ...
There's still time to get a flu shot
Feb 05, 2014
(HealthDay)—It's still not too late to get a flu shot, the U.S. Food and Drug Administration said Wednesday.
Severe flu complications for cancer patients
Nov 25, 2013
It is often noted that very young people and the elderly are most at-risk for experiencing flu-related complications, and one expert at the University of Alabama at Birmingham says people with weakened immune ...
Recommended for you
Young, unvaccinated adults account for severest flu cases
1 hour ago
A snapshot of patients who required care at Duke University Hospital during this year's flu season shows that those who had not been vaccinated had severe cases and needed the most intensive treatment.
MRI to offer advances in treatment for chronic kidney disease
2 hours ago
Detailed structural and functional 'maps' of the human kidney made using advanced scanning technology are to be developed by scientists at The University of Nottingham.
When you always gotta go...
3 hours ago
Problems related to urination, including incontinence and having to get up to urinate at night-time, have become more acceptable topics of discussion over recent years. New treatment options have also led doctors to address ...
Coach app gets lung patients moving
3 hours ago
Encouraging physical activity is an essential objective in treating COPD (chronic lung disease), but current treatment methods do not manage to effectively improve patients' daily activity behaviour. This ...
Explainer: What is H7N9 bird flu?
5 hours ago
Australia's federal Department of Health has advised general practitioners to be on the lookout for potential cases of the H7N9 strain of influenza A, or bird flu, following a spate of deaths in China. ...
Bacteria in the lungs make COPD patients sicker
5 hours ago
(Medical Xpress)—Conventional wisdom has held that even though bacteria persist in the lungs of patients with chronic, obstructive pulmonary disease (COPD), their presence, referred to as 'colonization,' ...
User comments
© Medical Xpress 2011-2014, Science X network
Paul Thomas, Ph.D., an assistant member of the Department of Immunology at St. Jude Children's Research Hospital, is corresponding author on a study that identifies factors that predict flu severity in patients and sets the stage for more effective therapies to prevent flu complications and deaths. Credit: Ann-Margaret Hedges, St. Jude Children's Research Hospital
St. Jude Children's Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue of the American Journal of Respiratory and Critical Care Medicine.
The discovery came after investigators tracked flu infections for 28 days in 84 individuals with community-acquired influenza. The study is still underway. This report focused on the 2009-2010 and 2010-2011 flu seasons.
Researchers found that patients with elevated levels of three particular immune system regulators, or cytokines, early in the infection were more likely to develop severe flu symptoms and to be hospitalized than patients with lower levels of the same regulators. Study participants ranged in age from 3 weeks to 71 years old and included 41 infants and toddlers aged 23 months or younger.
The cytokine levels early in the infection were predictive of flu-related complications regardless of patient age, flu strain, the ability of the virus to replicate and other factors. The cytokines involved help to regulate inflammation driven by the innate immune response. The innate immune system serves as the frontline of the body's defense against flu and other threats until antibodies and T cells are ready to provide a more targeted defense.
Study participants were recruited by research collaborators at Le Bonheur Children's Medical Center, a general children's hospital in Memphis, where patients are still being enrolled in the study. Researchers also plan to check for immune signatures in flu patients from sites in the U.S., Egypt, Colombia and other nations.
"Patients in this study could handle the flu virus and clear it from their lungs in a week to 10 days. The problem for patients with this immune signature is likely the inflammatory environment in their airways created by the innate immune system in response to the virus," said corresponding author Paul Thomas, Ph.D., an assistant member of the St. Jude Department of Immunology. "Clinically, we need to explore targeted therapies to address this problem separately from efforts to clear the virus."
The findings provide insight into why the benefits of the antiviral drug oseltamivir diminish early in the infection. "This drug helps get rid of the virus, but these patients do not appear to have a problem with that," Thomas explained.
Flu remains a leading cause of illness and death worldwide. In this study, 19 patients were hospitalized, including four who were admitted to an intensive care unit.
For this study, researchers tracked both the flu infection and the resulting immune response through blood, nasal swabs and nasal wash samples collected from patients with laboratory-confirmed flu. Sampling began when patients sought medical attention for flu symptoms and was repeated on days 3, 7, 10 and 28. Along with measuring levels of flu virus in the nose and sinuses, researchers measured 42 cytokines and antibodies against circulating flu viruses.
This is one of the first studies to examine the immune response in both the blood and in the nose and sinuses, where the infection begins. The patients included 24 who qualified as high risk for flu complications due to asthma and certain other underlying medical conditions. Similar sampling was conducted on 126 volunteers recruited from the households of flu patients.
The testing showed children and adults were equally successful at eliminating the virus regardless of the subtype. In fact, based on cytokine levels in the blood, nose and sinuses of patients, children mounted a more aggressive inflammatory response than adults. "The fact that the innate immune response was stronger in the airways of children than adults was a surprise. Previous studies using different measures reported that children mounted a weaker immune response," said first author Christine Oshansky, Ph.D., a St. Jude postdoctoral fellow. In this study, the hyperactive immune response diminished with age, but Thomas said it may help explain why toddlers and infants are more likely to develop severe flu symptoms. Normal genetic variation might play a role in the innate immune response, he added.
When researchers dissected the inflammatory response, they found that elevated nasal levels of the cytokines MCP-3 and interferon alpha 2 (IFNa2) and elevated blood levels of interleukin 10 (IL-10) at diagnosis predicted more severe symptoms later. Increased blood levels of IL-10 and MCP-3, as well as interleukin-6, at diagnosis predicted hospitalization later. MCP-3 and IFNa2 promote inflammation. IL-10 suppresses inflammation. Elevated IL-10 levels often signal that the body is trying to shut down the inflammatory response.
Researchers also found evidence linking inflammatory cytokine levels to white blood cells called monocytes that are recruited to the site of the infection. Through cytokine secretion and other activities, different types of monocytes have the ability to orchestrate a variety of inflammatory responses. Some responses are likely beneficial, but some may hinder patient recovery. Work has begun to better understand what regulates production and movement of different monocyte populations as a way to better explain differences in the inflammatory response to flu.
Explore further: Researchers identify risks for death from H7N9 avian flu virus
Medical Xpress on facebook
Related Stories
Researchers identify risks for death from H7N9 avian flu virus
Dec 24, 2013
(Medical Xpress)—Since March 2013, the avian flu virus H7N9 has infected 134 people and caused 44 deaths. Among those infected, many, but not all, patients develop severe symptoms, including pneumonia and ...
Study finds some people less susceptible to H7N9 influenza virus than others
Jan 07, 2014
(Medical Xpress)—An international team of researchers working at the University of Melbourne in Australia has found that genetic differences in people result in different degrees of ability to fight the ...
The rocky road to a better flu vaccine
Jan 23, 2014
Currently approved flu vaccines are less effective in the elderly, yet an estimated 90% of influenza-related deaths occur in people over 65. A paper published on January 23rd in PLOS Pathogens reports on the ...
There's still time to get a flu shot
Feb 05, 2014
(HealthDay)—It's still not too late to get a flu shot, the U.S. Food and Drug Administration said Wednesday.
Severe flu complications for cancer patients
Nov 25, 2013
It is often noted that very young people and the elderly are most at-risk for experiencing flu-related complications, and one expert at the University of Alabama at Birmingham says people with weakened immune ...
Recommended for you
Young, unvaccinated adults account for severest flu cases
1 hour ago
A snapshot of patients who required care at Duke University Hospital during this year's flu season shows that those who had not been vaccinated had severe cases and needed the most intensive treatment.
MRI to offer advances in treatment for chronic kidney disease
2 hours ago
Detailed structural and functional 'maps' of the human kidney made using advanced scanning technology are to be developed by scientists at The University of Nottingham.
When you always gotta go...
3 hours ago
Problems related to urination, including incontinence and having to get up to urinate at night-time, have become more acceptable topics of discussion over recent years. New treatment options have also led doctors to address ...
Coach app gets lung patients moving
3 hours ago
Encouraging physical activity is an essential objective in treating COPD (chronic lung disease), but current treatment methods do not manage to effectively improve patients' daily activity behaviour. This ...
Explainer: What is H7N9 bird flu?
5 hours ago
Australia's federal Department of Health has advised general practitioners to be on the lookout for potential cases of the H7N9 strain of influenza A, or bird flu, following a spate of deaths in China. ...
Bacteria in the lungs make COPD patients sicker
5 hours ago
(Medical Xpress)—Conventional wisdom has held that even though bacteria persist in the lungs of patients with chronic, obstructive pulmonary disease (COPD), their presence, referred to as 'colonization,' ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment